Literature DB >> 2538651

The actin domain of Gardner-Rasheed feline sarcoma virus inhibits kinase and transforming activities.

K Sugita1, J S Gutkind, S Katamine, T Kawakami, K C Robbins.   

Abstract

The transforming gene product, P70gag-actin-fgr, of Gardner-Rasheed feline sarcoma virus (GR-FeSV) is a single polypeptide composed of regions derived from cellular and viral genes. Gamma actin and c-fgr genes are the two known cellular components of the GR-FeSV genome. In the present study, sequences representing each cell-derived gene were deleted and the resulting constructs were tested for transforming activity by transfection of NIH 3T3 cells. Constructs lacking a portion of the c-fgr proto-oncogene failed to induce focus formation, demonstrating the essential nature of this component for GR-FeSV oncogenic activity. In contrast, the construct lacking the actin domain was more active than GR-FeSV DNA in transformation assays. Protein specified by the actin deletion mutant possessed a 2.4-fold greater specific protein-tyrosine kinase activity compared with that of the wild-type gene product. Furthermore, the actin domain had no detectable effect on the ability of the fgr kinase to associate with cytoskeleton or to phosphorylate unique cellular proteins on tyrosine. Our findings demonstrate that the actin domain inhibits focus formation and impairs protein-tyrosine kinase activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538651      PMCID: PMC248428     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

2.  Acquisition of transforming properties by FYN, a normal SRC-related human gene.

Authors:  T Kawakami; Y Kawakami; S A Aaronson; K C Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

3.  Variations in expression of mutant beta actin accompanying incremental increases in human fibroblast tumorigenicity.

Authors:  J Leavitt; G Bushar; T Kakunaga; H Hamada; T Hirakawa; D Goldman; C Merril
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Origin and biological properties of a new feline sarcoma virus.

Authors:  S Rasheed; M Barbacid; S Aaronson; M B Gardner
Journal:  Virology       Date:  1982-02       Impact factor: 3.616

Review 6.  Cellular oncogenes and retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  Gene product of v-fgr onc: hybrid protein containing a portion of actin and a tyrosine-specific protein kinase.

Authors:  G Naharro; K C Robbins; E P Reddy
Journal:  Science       Date:  1984-01-06       Impact factor: 47.728

8.  In vivo identification of the transforming gene product of simian sarcoma virus.

Authors:  K C Robbins; S G Devare; E P Reddy; S A Aaronson
Journal:  Science       Date:  1982-12-10       Impact factor: 47.728

9.  Analysis of the primary translational product and integrated DNA of a new feline sarcoma virus, GR-FeSV.

Authors:  G Naharro; C Y Dunn; K C Robbins
Journal:  Virology       Date:  1983-03       Impact factor: 3.616

10.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  3 in total

1.  Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release.

Authors:  M Benhamou; J S Gutkind; K C Robbins; R P Siraganian
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes.

Authors:  J S Gutkind; D C Link; S Katamine; P Lacal; T Miki; T J Ley; K C Robbins
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

3.  Characterization of the transforming domain of a feline sarcoma virus encoding a fgr-related tyrosine kinase.

Authors:  G Weyrauch; A Barnekow
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.